mir-218-2 promotes glioblastomas growth, invasion and drug resistance by targeting CDC27.
about
mir-218-2 promotes glioblastomas growth, invasion and drug resistance by targeting CDC27.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 December 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
mir-218-2 promotes glioblastomas growth, invasion and drug resistance by targeting CDC27.
@en
mir-218-2 promotes glioblastomas growth, invasion and drug resistance by targeting CDC27.
@nl
type
label
mir-218-2 promotes glioblastomas growth, invasion and drug resistance by targeting CDC27.
@en
mir-218-2 promotes glioblastomas growth, invasion and drug resistance by targeting CDC27.
@nl
prefLabel
mir-218-2 promotes glioblastomas growth, invasion and drug resistance by targeting CDC27.
@en
mir-218-2 promotes glioblastomas growth, invasion and drug resistance by targeting CDC27.
@nl
P2093
P2860
P356
P1433
P1476
mir-218-2 promotes glioblastomas growth, invasion and drug resistance by targeting CDC27.
@en
P2093
Guoying Feng
Junchen Zhou
Luping Zhang
Shuai Zhou
Wenhua Huang
Zhuoying Feng
P2860
P304
P356
10.18632/ONCOTARGET.13850
P407
P577
2016-12-10T00:00:00Z